Sopharma AD (WSE:SPH)
12.75
-0.25 (-1.92%)
Oct 24, 2025, 7:51 AM CET
Sopharma AD Revenue
Sopharma AD had revenue of 637.01M BGN in the quarter ending June 30, 2025, with 28.75% growth. This brings the company's revenue in the last twelve months to 2.41B, up 22.15% year-over-year. In the year 2024, Sopharma AD had annual revenue of 2.14B with 13.27% growth.
Revenue (ttm)
2.41B BGN
Revenue Growth
+22.15%
P/S Ratio
0.57
Revenue / Employee
430.85K BGN
Employees
5,599
Market Cap
2.97B PLN
Revenue Chart
* This company reports financials in BGN.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.14B | 250.64M | 13.27% |
| Dec 31, 2023 | 1.89B | 217.31M | 13.00% |
| Dec 31, 2022 | 1.67B | 60.17M | 3.73% |
| Dec 31, 2021 | 1.61B | 165.21M | 11.42% |
| Dec 31, 2020 | 1.45B | 158.02M | 12.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.04B |
| Diagnostyka | 2.17B |
| Centrum Medyczne ENEL-MED | 789.78M |
| Synektik Spólka Akcyjna | 623.20M |
| Mercator Medical | 579.83M |
| Voxel | 560.38M |
| Selvita | 373.90M |
| Celon Pharma | 206.22M |